Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|July 21, 2017
Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional studyAne Løvli Stav, Krisztina Kunszt Johansen, Eirik Auning, et al.
Frontiers in Aging Neuroscience|March 12, 2024
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohortsMostafa Mehdipour Ghazi, Per Selnes, Santiago Timón-Reina, et al.
Neuroscience Letters|March 1, 2017
Mitochondrial transcription factor A (TFAM) rs1937 and AP endonuclease 1 (APE1) rs1130409 alleles are associated with reduced cognitive performanceMeryl S Lillenes, Mari Støen, Clara-Cecilie Günther, et al.
Dementia and Geriatric Cognitive Disorders Extra|June 28, 2024
Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid PathologyCecilia Magdalena Eriksson, Bjørn-Eivind Kirsebom, Ragna Espenes, et al.
Brain Communications|May 5, 2025
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's diseaseStephanie Knudtzon, Kaja Nordengen, Lene Pålhaugen, et al.
Journal of Parkinson'S Disease|April 11, 2016
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's DiseasesErik Hessen, Ane Løvli Stav, Eirik Auning, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2018
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's diseaseBjørn-Eivind Kirsebom, Kaja Nordengen, Per Selnes, et al.
Molecular Brain|May 29, 2016
Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's diseaseMeryl S Lillenes, Alberto Rabano, Mari Støen, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairmentPer Selnes, Dag Aarsland, Atle Bjørnerud, et al.
Frontiers in Aging Neuroscience|June 12, 2023
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trialLuiza Jadwiga Chwiszczuk, Monica Haraldseid Breitve, Bjørn-Eivind Bordewick Kirsebom, et al.
Pageof 6